Sigrid S. Skånland

Also affiliated with University of Oslo, Cancer Registry of Norway

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Outcomes of COVID-19 in patients with CLL: a multicenter international experience”.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Blood(2021)10.1182/blood.2021011841

N/A

3.5DataRank · unranked

70 citations

Toby A. Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids +47 more

Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1221

N/A

0.385DataRank · unranked

12 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient

Cell Death & Disease(2025)10.1038/s41419-025-07884-7

N/A

0.208DataRank · unranked

3 citations

Paschalis Athanasiadis, Yanping Yin, Anne-Sofie F. Rise, Alberto J. Arribas, Luciano Cascione +8 more

Functional testing of PI3K inhibitors stratifies responders to idelalisib and identifies treatment vulnerabilities in idelalisib-refractory/intolerant chronic lymphocytic leukemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.14.488428

N/A

0DataRank · unranked

1 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Ishwarya Murali, Stacey M. Fernandes +11 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Data from Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia

(2023)10.1158/1078-0432.c.6532718.v1

N/A

0DataRank · unranked

0 citations

Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali +12 more

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127

Science(2024)10.1126/science.adi5798

N/A

0DataRank · unranked

152 citations

Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C. Thompson, Alexandra Chirino +48 more

PI3K Inhibitors in Hematology: When One Door Closes…

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0967

N/A

0DataRank · unranked

23 citations

Klaus Okkenhaug, Matthew S. Davids, Sigrid S. Skånland

Mcl‐1 and Bcl‐xL levels predict responsiveness to dual MEK/Bcl‐2 inhibition in B‐cell malignancies

Molecular Oncology(2021)10.1002/1878-0261.13153

N/A

0DataRank · unranked

17 citations

Mariaserena Giliberto, Linda Karlsen, Pilar Ayuda‐Durán, Robert Hanes, Toril Holien +6 more